21.2 C
New York
Thursday, June 18, 2026

Tag: root

Reed’s to Participate in OTC Markets Virtual Investor Conference on June 26

NORWALK, Conn., June 18, 2025 (GLOBE NEWSWIRE) -- Reed’s, Inc. (OTCQX: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, natural ginger beverages, today announced its participation in the upcoming OTC Markets Virtual Investor Conference on Thursday, June 26, 2025.

Mainframe Modernization Services Market to Reach USD 76.16 Billion by 2032, Growing at a CAGR of 15.1%: Credence Research

PUNE, India, June 18, 2025 /PRNewswire/ -- According to a recent market analysis published by Credence Research, the global Mainframe Modernization Services Market is set...

Intellias at Software-Defined Vehicles USA 2025: Special Plenary Presentation Will Examine “The Fragmented Future of the Software-Defined Vehicle – Cooperation or Chaos?”

Company to Showcase Newest Functions of its "IntelliKit" Chip-To-Cloud Automotive Technology Platform CHICAGO, June 18, 2025 /PRNewswire/ -- Leading OEM software engineering partner and solution provider...

Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030

PALM BEACH, Fla., June 18, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The market for abuse-deterrent opioids is still developing, but it's estimated that replacing extended-release opioids with abuse-deterrent formulations could lead to significant cost savings and a reduction in abuse-related medical events. While specific revenue figures for the abuse-deterrent opioid market are not readily available, the potential impact on the broader opioid market is substantial. One such report from Roots Analysis, however, did project revenues, saying: “The abuse deterrent formulations market is estimated to grow from USD 25.7 million in 2024 to reach USD 39.8 million in 2025 and USD 54.8 million by 2030, representing a higher CAGR of 6.6% during the forecast period. Although the healthcare industry relies on patient to take medications responsibly, in 2017, close to 18 million individuals were reported to have misused prescription drugs, in the US. In fact, data from a National Survey on Drug Use and Health conducted in the same year, showed that an estimated 2 million Americans misused prescription pain relievers for the first time in the previous year. Moreover, the same study reported 1.5 million people abusing tranquilizers, over 1 million abusing prescription stimulants and more than 270,000 abusing sedatives, for the first time, in the same time period. Owing to a rapid onset of medicinal effect, which offers immediate relief (with high efficacy), opioids are still considered to be one of the most widely used pharmacological interventions for pain management. However, these drugs are known to induce a euphoric state upon consumption, often causing patients to abuse them; increased recreational use of opioids is known to lead to addiction. Moreover, over-prescription of such medicinal products, which promotes their misuse, is considered as one of the root causes of the opioid crisis (increasing number of deaths involving misuse and addiction to opioids), in the US. According to the Centers for Disease Control and Prevention (CDC), more than 72,000 overdose-related deaths were reported in 2017, of which close to 50,000 involved the use of an opioid.”   Active healthcare/tech companies active in the markets include: Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW), Pfizer Inc. (NYSE: PFE), Collegium Pharmaceutical, Inc. (NASDAQ: COLL), Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), Emergent BioSolutions Inc. (NYSE: EBS).

Drilling Underway at Northern Shield’s Root & Cellar Property Targeting Epithermal Gold-Tellurium-Silver Mineralization

OTTAWA, ON, June 18, 2025 /CNW/ - Northern Shield Resources Inc. ("Northern Shield" or the "Company") is pleased to announce that diamond drilling has...

IRSA: China as the Global Tourism Industry’s “New Engine”: A Comprehensive Leap from Policy Innovation to Market Vitality

New York, June 18, 2025 (GLOBE NEWSWIRE) -- According to the latest report from the World Travel & Tourism Council (WTTC), China is accelerating toward the ranks of global tourism industry "leaders" through its open approach and innovative practices. In 2025, China's domestic tourism market is projected to exceed RMB 13.7 trillion yuan, injecting robust momentum into the global economy while creating over 83 million jobs. Behind this achievement lies the multi-faceted driving force of China's policy dividends, industrial integration, and consumption upgrading, showcasing China's advantages in openness and inclusiveness, traditional culture, technological advancement, and secure environment. These strengths are attracting international visitors in droves, establishing China as the global tourism industry's "new engine."

Potomac Edison Employee Volunteers Plant 2,000+ Donated Trees in Maryland and West Virginia

Total helps put FirstEnergy on pace to exceed 2025 tree donation goal WILLIAMSPORT, Md., June 17, 2025 /PRNewswire/ -- Employee volunteers from Potomac Edison, a...

Reishi™ in the Nordic Light – A New Era of Tactile, Timeless Design

Presenting a new collection of objects co-created with visionary Danish designers and MycoWorks - curated by Marie-Louise Høstbo. 3 Days of Design, Copenhagen 2025, June 18...

Slimjaro: Examining the Science and Safety of a Legal Slim Jaro Weight loss Health Formula

Jacksonville, FL, June 17, 2025 (GLOBE NEWSWIRE) -- Weight loss is a humongous challenge that many people struggle with. Lack of motivation to continue a healthy lifestyle, diet, exercise, and hormonal imbalance, pave the path for weight loss supplements for an obese person. SlimJaro emerged as a trending fruitful and healthy weight loss product. It offers the perfect blend of natural ingredients, providing sustainable, long-lasting, and safe results.

RumChata Invites Fans to “Spike” the Viral Dirty Soda Trend with Reality Star Jessi Ngatikaura

Fans can share their own "spiked" dirty soda recipes for a chance to win a trip to Salt Lake City to meet Jessi and...

About Fresh and Neighborhood Healthcare Partner to Launch Innovative Fresh Connect Produce Prescription Pilot to Improve Health Outcomes for Diabetic Patients

BOSTON, June 17, 2025 /PRNewswire/ -- Today About Fresh, a non-profit dedicated to advancing social innovation at the intersection of food and healthcare systems,...

Baltimore Expands Use of Evolve™ Rodent Birth Control Following Successful Pilot

Full Scale Implementation Expected SURPRISE, Ariz., June 13, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a leader in fertility control solutions...

Celldex Presents Unprecedented 76 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI Congress 2025

HAMPTON, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today new data demonstrating profound, sustained complete response and improved quality of life at 76 weeks, 7 months after the completion of dosing with barzolvolimab in chronic spontaneous urticaria (CSU), an immune-related condition driven by mast cell activation. Barzolvolimab specifically targets mast cells by binding the receptor tyrosine kinase KIT with high specificity and potently inhibiting its activity, which is required for mast cell function and survival.

Blueprint Medicines Announces Data Reinforcing Sustained Clinical Efficacy and Well-Tolerated Safety Profile of Long-Term AYVAKIT®/AYVAKYT® (avapritinib) Treatment at 2025 EHA and EAACI Congresses

-- Breadth of presentations, including one oral and two flash talks, showcase Blueprint Medicines' leadership role in advancing care for patients with systemic mastocytosis...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRoot